A 52-year-old man with a 10-year history of duodenal ulcer disease presents with epigastric pain and heartburn. Upper endoscopy confirms an active duodenal ulcer. He is H. pylori-positive on rapid urease test. What is the drug of choice for initial eradication therapy in this patient?
A. Omeprazole + amoxicillin + clarithromycin
B. Ranitidine + bismuth subsalicylate
C. Omeprazole monotherapy
D. Sucralfate + metronidazole
Explanation
H. pylori Eradication Therapy in Peptic Ulcer Disease
Key Point
Triple therapy combining a proton pump inhibitor (PPI) with two antibiotics is the gold-standard first-line regimen for H. pylori eradication in peptic ulcer disease.
Standard Triple Therapy Regimen
High-YieldNEET PG
The most widely recommended and effective triple therapy consists of:
Proton pump inhibitor (omeprazole, lansoprazole, or pantoprazole)
Amoxicillin (or metronidazole if penicillin-allergic)
Clarithromycin (or metronidazole as alternative)
This combination achieves eradication rates of 85–95% when compliance is maintained.
Mechanism of Action
Table
Component
Role
Mechanism
PPI (Omeprazole)
Acid suppression
Inhibits H+/K+-ATPase; creates alkaline environment for antibiotic penetration
Amoxicillin
Bactericidal antibiotic
β-lactam; disrupts bacterial cell wall
Clarithromycin
Bactericidal antibiotic
Macrolide; inhibits bacterial protein synthesis
Clinical Pearl
The PPI is essential not only for symptom relief but also to reduce gastric acidity, which enhances antibiotic bioavailability and H. pylori susceptibility.
Duration and Compliance
Key Point
Standard triple therapy is administered for 7–14 days (typically 10 days in India). Compliance is critical—incomplete courses lead to antibiotic resistance and treatment failure.
Why This Regimen Works
1.
Synergistic effect: The combination targets H. pylori through multiple mechanisms simultaneously.
2.
Resistance prevention: Dual antibiotic coverage reduces the likelihood of resistance emergence.
3.
Acid suppression: PPI-induced hypochlorhydria creates an optimal milieu for antibiotic penetration into gastric mucosa.